Importantly, cardiovascular benefits of GLP-1RAs appear to be independent of glycaemic control, with evidence supporting MACE risk reduction in non-diabetic populations [4]
In patients with T2D, the global NAFLD prevalence has increased by +50.09% [45.52% (25.01-67.57) in 1990-2004 to 68.32% (63.20-73.04)] in 2016-2021 (p=0.008)
APLB Glutathione Niacinamide Ampoule Serum is a must-have for anyone who wants brighter, healthier, and glowing skin
Depress Res Treat
"So we set out to use technology that allows everybody access to a clinically effective weight program tailored to each individual patient to not only create a more cost effective solution, but one that gets great outcomes." FlyteHealth's digital program gives employees access to personalized therapy for obesity by using an AI algorithm that provides tailored treatment plans
(PubMed) Iyer R, Gupta A, Khan A, Hiremath S, Lokhandwala Y